[go: up one dir, main page]

AR015586A1 - PHARMACEUTICAL COMPOSITION OF GASTRIC RESIDENCE. - Google Patents

PHARMACEUTICAL COMPOSITION OF GASTRIC RESIDENCE.

Info

Publication number
AR015586A1
AR015586A1 ARP980101773A ARP980101773A AR015586A1 AR 015586 A1 AR015586 A1 AR 015586A1 AR P980101773 A ARP980101773 A AR P980101773A AR P980101773 A ARP980101773 A AR P980101773A AR 015586 A1 AR015586 A1 AR 015586A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
gastric residence
carbon dioxide
benzamide
allows
Prior art date
Application number
ARP980101773A
Other languages
Spanish (es)
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of AR015586A1 publication Critical patent/AR015586A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Anesthesiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composicion farmacéutica de residencia gástrica que comprende: (a)un principio activo que consiste en una benzamida o una sal de benzamida, (b)un sistemagenerador de dioxido de carbono, y (c)un medio que permite la retencion parcial del dioxido de carbono generado por dicho sistema generador de dioxido decarbono.Pharmaceutical composition of gastric residence comprising: (a) an active substance consisting of a benzamide or a benzamide salt, (b) a carbon dioxide system, and (c) a means that allows the partial retention of carbon dioxide generated by said carbon dioxide generating system.

ARP980101773A 1997-04-18 1998-04-17 PHARMACEUTICAL COMPOSITION OF GASTRIC RESIDENCE. AR015586A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9704803A FR2762213B1 (en) 1997-04-18 1997-04-18 PHARMACEUTICAL COMPOSITION WITH GASTRIC RETENTION

Publications (1)

Publication Number Publication Date
AR015586A1 true AR015586A1 (en) 2001-05-16

Family

ID=9506077

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980101773A AR015586A1 (en) 1997-04-18 1998-04-17 PHARMACEUTICAL COMPOSITION OF GASTRIC RESIDENCE.

Country Status (19)

Country Link
EP (1) EP0983065A1 (en)
JP (1) JP2001523241A (en)
KR (1) KR20010006353A (en)
CN (1) CN1252720A (en)
AR (1) AR015586A1 (en)
AU (1) AU737634B2 (en)
CA (1) CA2286081A1 (en)
FR (1) FR2762213B1 (en)
HU (1) HUP0002455A3 (en)
IL (1) IL131995A0 (en)
JO (1) JO2017B1 (en)
MA (1) MA26482A1 (en)
NO (1) NO995039L (en)
NZ (1) NZ500288A (en)
PE (1) PE68199A1 (en)
PL (1) PL336273A1 (en)
TN (1) TNSN98049A1 (en)
WO (1) WO1998047506A1 (en)
ZA (1) ZA983258B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6169094B1 (en) * 1998-07-14 2001-01-02 Sanofi-Synthelabo Compositions of (S) (-)-amisulpride
FR2784583B1 (en) * 1998-10-16 2002-01-25 Synthelabo PHARMACEUTICAL COMPOSITION WITH GASTRIC RESIDENCE AND CONTROLLED RELEASE
FR2790388B1 (en) * 1999-03-04 2001-04-13 Synthelabo PHARMACEUTICAL COMPOSITIONS COMPRISING A BENZAMIDE AND AT LEAST ONE ABSORPTION PROMOTER
EP1245227A1 (en) 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
WO2009157711A2 (en) * 2008-06-24 2009-12-30 Park Eun-Seok Gastro-retentive porous tablet and method for preparing same
FR2949061B1 (en) * 2009-08-12 2013-04-19 Debregeas Et Associes Pharma FLOATING MICROGRANULES
PT2719376E (en) 2012-10-12 2015-07-06 Omya Int Ag Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate
EP3720435B1 (en) 2017-12-05 2024-03-06 Sunovion Pharmaceuticals Inc. Crystal forms and production methods thereof
SG11202005016SA (en) 2017-12-05 2020-06-29 Sunovion Pharmaceuticals Inc Nonracemic mixtures and uses thereof
JP7044649B2 (en) * 2018-06-28 2022-03-30 株式会社ファンケル Intragastric floating tablets
CN114401717A (en) 2019-06-04 2022-04-26 赛诺维信制药公司 Modified release formulations and their uses
WO2023214018A1 (en) 2022-05-06 2023-11-09 Galenix Innovations Gastro-retentive swellable sustained release composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2415099A1 (en) * 1978-01-20 1979-08-17 Ile De France NEW DERIVATIVES OF 4-AMINO-5-ALKYLSULFONYL ORTHO-ANISAMIDES, THEIR METHODS OF PREPARATION AND THEIR APPLICATION AS PSYCHOTROPES
FR2554718B1 (en) * 1983-11-14 1986-04-04 Ethypharm Sa NEW ORAL SULPIRIDE FORMS FOR SULPIRIDE
FR2556964A1 (en) * 1983-12-23 1985-06-28 Ile De France NEW GALENIC FORMS OF SULPIRIDE USED ORALALLY
JPS62178518A (en) * 1986-01-30 1987-08-05 Toho Yakuhin Kogyo Kk New long-acting sulpiride tablets
JPH0776172B2 (en) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 Matrice locks
CA2039742A1 (en) * 1990-04-23 1991-10-24 Andrew B. Dennis Tablet composition and method for problem pharmaceutical materials

Also Published As

Publication number Publication date
PL336273A1 (en) 2000-06-19
IL131995A0 (en) 2001-03-19
WO1998047506A1 (en) 1998-10-29
NO995039D0 (en) 1999-10-15
MA26482A1 (en) 2004-12-20
NO995039L (en) 1999-12-17
FR2762213B1 (en) 1999-05-14
HUP0002455A2 (en) 2000-12-28
HUP0002455A3 (en) 2001-01-29
AU737634B2 (en) 2001-08-23
AU7341698A (en) 1998-11-13
TNSN98049A1 (en) 2005-03-15
FR2762213A1 (en) 1998-10-23
CA2286081A1 (en) 1998-10-29
ZA983258B (en) 1998-10-19
JP2001523241A (en) 2001-11-20
PE68199A1 (en) 1999-07-15
CN1252720A (en) 2000-05-10
JO2017B1 (en) 1999-05-15
NZ500288A (en) 2001-03-30
EP0983065A1 (en) 2000-03-08
KR20010006353A (en) 2001-01-26

Similar Documents

Publication Publication Date Title
CY1107675T1 (en) TRAMADOLIS MEDICINES
CY1107841T1 (en) PHARMACEUTICAL PARTICULARS CONTAINING MYCOPHENOLIC ACID OR MYCOPHENOLATE SALT
AR015586A1 (en) PHARMACEUTICAL COMPOSITION OF GASTRIC RESIDENCE.
CY1107181T1 (en) Combination of herbicides with acylated aminophenylsulfonylureas
CY1105154T1 (en) INCORPORATION OF ACTIVE INGREDIENTS INTO CARRIER MATRICES
ES2051881T3 (en) PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL FORMULATION OF PROLONGED RELEASE.
DK0960107T3 (en) 6-Thiosubstituted paclitaxels
DK0703802T3 (en) Intravaginal active substance delivery system
MX9204625A (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF A MAMMAL SPECIES, WHICH SUFFERS FROM CONGESTIVE HEART DEFICIENCY.
ATE141131T1 (en) FUNGICIDAL ACTIVE COMBINATIONS
ES2171416T3 (en) REMEDY AGAINST THROMBOCITOPENIA.
ECSP034613A (en) LIOFILIZED PREPARATION OF PANTOPRAZOL AND INJECTION OF PANTOPRAZOL
ME00578A (en) Use of gastrointestinal lipase inhibitors
DE60233251D1 (en) 4,4-DIFLUOR-1,2,3,4-TETRAHYDRO-5H-1-BENZAZEPINE DERIVATIVES AND THEIR SALTS
TR200103119T2 (en) Substance for the treatment of dry eye.
ATE260650T1 (en) ORAL DOSAGE FORMS FOR ADMINISTRATION OF A FIXED COMBINATION OF TRAMADOL AND DICLOFENAC
AR034493A1 (en) COMBINATION OF ACTIVE PRINCIPLES FOR THE MEDICAL TREATMENT OF TOXICOMANS.
ATE240303T1 (en) 1,2,4-TRIAZOLE-3-THIONE COMPOUNDS
ES2080037T3 (en) TOPIC USE MEDICATION WITH CICATRIZING ACTIVITY.
BR9608255A (en) Transdermal therapeutic system (stt) for testosterone administration
CY1105620T1 (en) CONTAINER FOR HYPODERMAL SYRINGE
TR200102024T2 (en) New treatment.
ES2084741T3 (en) HERBICIDE COMPOSITION.
CY1105463T1 (en) CONTROLLED ADMINISTRATION OF ANTI-ADPHILISTICS
NO954702L (en) Aryl forming drugs